Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients

• Main Authors: David Medved, Thomas Clausen, Anne Bukten, Ronny Bjørnestad, Ashley Elizabeth Muller
• Format: Article
• Language: English
• Published: BMC 2020-11-01
• Series: Substance Abuse Treatment, Prevention, and Policy
• Subjects: Opioid maintenance treatment; Opioids; Somatic disease burden; Ageing; Chronic disease; Mental distress
• Online Access: http://link.springer.com/article/10.1186/s13011-020-00311-4

Abstract Objectives To describe and explore somatic disease burdens of ageing long-term patients in opioid maintenance treatment (OMT), a unique population emerging in countries offering OMT as a long-term treatment. Methods We used data from the Norwegian Cohort of Patient in Opioid Maintenance Treatment and Other Drug Treatment Study (NorComt). 156 patients enrolled for at least three of the past five years provided data during structured interviews, including on chronic conditions, somatic treatment received, mental distress (SCL-25), and treatment satisfaction. A somatic disease burden was calculated from a list measuring the recent severity of 16 somatic complaints. A hierarchical multiple linear regression analysis identified correlates of somatic disease burden. Results Over half of patients reported at least seven somatic complaints. Reported somatic disease burden was associated with higher mental distress, more chronic conditions, fewer years in OMT, and treatment dissatisfaction. Age was unrelated, and there were few gender differences. These five variables explained 43.6% of the variance in disease burden. Conclusion Long-term OMT patients experience a large range of somatic complaints, and at non-acute levels. As OMT secures longevity for opioid-dependent persons, the clinical focus must be adjusted from acute to chronic care. Providers must address how to optimize health and quality of life while in treatment, as treatment may last for many years.